Nonopioid Pain Management Pathways for Stone Disease
Journal of Endourology · 2024
DOI: 10.1089/end.2023.0266 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Endourology, 2024. Verfasst von Jackson J S Cabo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Kidney Calculi, Renal Colic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Introduction
New opioid dependency after urologic surgery is a serious adverse outcome that is well-described in the literature. Patients with stone disease often require multiple procedures because of recurrence of disease and hence are at greater risk for repeat opioid exposures. Despite this, opioid prescribing after urologic surgery remains highly variable and in an emergency setting, opioids are still used commonly in management of acute renal colic.
Methods
Two literature searches were performed using PubMed. First, we searched available literature concerning opioid-sparing pathways in acute renal colic. Second, we searched available literature for opioid-sparing pathways in ureteroscopy and percutaneous nephrolithotomy (PCNL). Abstracts were reviewed for inclusion in our narrative review.
Results
In the setting of acute renal colic, multiple randomized control trials have shown that nonsteroidal anti-inflammatory drugs (NSAIDs) attain greater reduction in pain scores, decreased need for rescue medications, and decreased vomiting events in comparison with opioids. NSAIDs also form a core component in management of postureteroscopy pain and have been demonstrated in randomized trials to have equivalent to improved pain control outcomes compared with opioids. Multiple opioid-free pathways have been described for postureteroscopy analgesia with need for rescue narcotics falling under 20% in most studies, including in patients with ureteral stents. Enhanced Recovery After Surgery protocols after percutaneous nephrolithotomy are less well described but have yielded a reduction in postoperative opioid requirements.
Conclusions
In select patients, both acute renal colic and after kidney stone surgery, adequate pain management can usually be obtained with minimal or no opioid medication. NSAIDs form the core of most described opioid-sparing pathways for both ureteroscopy and PCNL, with the contribution of other components to postoperative pain outcomes limited because of lack of head-to-head comparisons. However, medications aimed specifically at targeting stent-related discomfort form a key component of most multimodal postsurgical pain management pathways. Further investigation is needed to develop pathways in patients unable to tolerate NSAIDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
ORCID-Profile: Jackson J S Cabo
Zitieren
APA
Cabo, J. J. S., & Miller, N. L. (2024). Nonopioid Pain Management Pathways for Stone Disease. Journal of Endourology. https://doi.org/10.1089/end.2023.0266
Vancouver
Cabo JJS, Miller NL. Nonopioid Pain Management Pathways for Stone Disease. Journal of Endourology. 2024. doi:10.1089/end.2023.0266
BibTeX
@article{Cabo2024,
author = {Cabo, Jackson J S and Miller, Nicole L},
title = {Nonopioid Pain Management Pathways for Stone Disease},
journal = {Journal of Endourology},
year = {2024},
doi = {10.1089/end.2023.0266}
}
EUVIMED